Trial Profile
first in human phase 1 study to support the early diagnosis and clinical management of Parkinson's disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 27 Mar 2018
Price :
$35
*
At a glance
- Drugs Tau PET imaging agents-AC Immune/Piramal Imaging (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Diagnostic use; First in man
- 27 Mar 2018 New trial record
- 20 Mar 2018 According to an AC Immune media release, company commenced this study in the the second half of 2018.